Company intelligence / Profile preview

Medtrum Technologies

Shanghai, Shanghai, China

Ownership: Private
Employees: ~29
Development stage: Other

Overview

Medtrum has commercialized a suite of diabetes management devices including tubeless insulin pumps and continuous glucose monitors. The company’s products are designed for both home and clinical use. They are also developing semi closed-loop/artificial pancreas systems to further automate diabetes care. No clinical trial results are publicly available; the focus appears to be on device innovation and commercialization rather than drug development.

Therapeutic areas: Endocrinology
Modalities: DeviceDigital health solution (for diabetes management)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Medtrum Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medtrum Technologies.

Explore the full profile